Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glutamate receptor, metabotropic 5 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0172 | 0.4266 | 0.9791 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0333 | 0.9223 | 0.5 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0048 | 0.0427 | 0.2169 |
Onchocerca volvulus | 0.0175 | 0.4357 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.2054 | 0.4714 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.012 | 0.2667 | 0.612 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0103 | 0.2145 | 0.2145 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0048 | 0.0427 | 0.0981 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.4266 | 0.9791 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0175 | 0.4357 | 1 |
Loa Loa (eye worm) | glutamate receptor | 0.0098 | 0.1971 | 0.4523 |
Echinococcus granulosus | 6 phosphofructo 2 kinase:fructose 2 | 0.0175 | 0.4357 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0075 | 0.1263 | 0.2898 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0111 | 0.2383 | 0.5471 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0175 | 0.4357 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0103 | 0.2145 | 0.2145 |
Loa Loa (eye worm) | hypothetical protein | 0.0175 | 0.4357 | 1 |
Giardia lamblia | Hypothetical protein | 0.0103 | 0.2145 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0359 | 1 | 1 |
Trichomonas vaginalis | Clan MA, family M1, aminopeptidase N-like metallopeptidase | 0.0034 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M1, aminopeptidase N-like metallopeptidase | 0.0034 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0075 | 0.1263 | 0.2898 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.012 | 0.2667 | 0.612 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0175 | 0.4357 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.0075 | 0.1263 | 0.2898 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0075 | 0.1263 | 0.2898 |
Loa Loa (eye worm) | glutamate receptor | 0.0038 | 0.0144 | 0.0331 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0172 | 0.4266 | 0.9791 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0175 | 0.4357 | 1 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0082 | 0.1482 | 0.3402 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0082 | 0.1482 | 0.3402 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.2667 | 0.612 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0172 | 0.4266 | 0.9791 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0175 | 0.4357 | 1 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0098 | 0.1971 | 1 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0089 | 0.1688 | 0.8563 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0175 | 0.4357 | 1 |
Giardia lamblia | Hypothetical protein | 0.0103 | 0.2145 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0103 | 0.2145 | 1 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0082 | 0.1482 | 0.3402 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0172 | 0.4266 | 0.9791 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.493 uM | Negative allosteric modulation of human mGluR5 expressed in CHO cells assessed as inhibition of L-quisqualate-induced intracellular cAMP accumulation treated 5 mins before L-quisqualate addition by FLIPR assay | ChEMBL. | 23856046 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.